Markets:

Overview

News

Currencies

International

Treasuries

Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

37.85 +0.08 (+0.23%)

Streaming Delayed Price Updated: 2:53 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Terns Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗

January 14, 2026

Via Stocktwits

Stay updated with the stocks that are on the move in today's after-hours session. ↗

January 02, 2026

Via Chartmill

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

One fast-rising biotech just landed a heavyweight backer ahead of a pivotal presentation—here’s what investors should watch.

Via The Motley Fool

Topics Regulatory Compliance

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗

November 17, 2025

Via Benzinga

Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday ↗

November 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

Which stocks are moving on Monday? ↗

November 03, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday ↗

November 03, 2025

Via Benzinga

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades ↗

November 03, 2025

Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.

Via Benzinga

Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session. ↗

November 03, 2025

Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 03, 2025

Via Benzinga

Gapping stocks in Monday's session ↗

November 03, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data? ↗

October 22, 2025

Terns Pharmaceuticals announces 12-week Phase 2 results for oral obesity drug TERN-601, showing up to 4.6% weight loss but reporting cases of drug-induced liver injury.

Via Benzinga

Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 22, 2025

Via Benzinga

Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

October 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 21, 2025

Via Benzinga

Which stocks are moving after the closing bell on Tuesday? ↗

October 21, 2025

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

2 Under-the-Radar Stocks That Could Soar ↗

September 21, 2025

They could ride the wave of the hottest therapeutic area in the industry.

Via The Motley Fool

Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations

August 07, 2025

Indianapolis, IN – Shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) experienced a significant downturn, plummeting over 10% in premarket trading and continuing to slide throughout the...

Via MarketMinute

Topics Economy

Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors ↗

August 07, 2025

Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising trial updates.

Via Benzinga

Terns (TERN) Q2 Net Loss Narrows 16% ↗

August 06, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 20, 2025

Via Benzinga

Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday ↗

June 10, 2025

Via Benzinga

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street ↗

March 09, 2025

Via The Motley Fool

Top 3 Health Care Stocks You'll Regret Missing In Q4 ↗

November 19, 2024

Via Benzinga

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

October 31, 2024

Via Benzinga

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer ↗

October 04, 2024

Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.

Via Investor's Business Daily

This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments ↗

September 18, 2024

Terns has a modest market cap of less than $800 million, and its possible upside could be massive.

Via The Motley Fool

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday ↗

September 18, 2024

Via Benzinga

Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. ↗

September 15, 2024

Terns Pharmaceuticals just proved that it's competitive in the weight loss field.

Via The Motley Fool

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

Headline News about Terns Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today